申请人:Hoffmann-La Roche Inc.
公开号:US07368454B2
公开(公告)日:2008-05-06
The present invention relates to methods for treating 5-HT5A receptor related diseases which comprises administering compounds of formula I
wherein
R1, R2, aryl, and n are defined in the specification and pharmaceutically acceptable acid addition salts thereof.
本发明涉及治疗5-HT5A受体相关疾病的方法,其包括给予公式I的化合物,其中R1、R2、芳基和n在说明书中定义,以及其药学上可接受的酸盐。